GlassScriptPhysician profile
Robert J Muelleman
NPI 1700447661
$8,659.95
in general payments reported to CMS, 2019-2025
6 companies · $294 in 2025
The $294 reported for 2025 was more than what 86% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $7,858 · 2024: $508 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Travel and Lodging: $1,696 · Food and Beverage: $1,197 · Education: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Travel and Lodging | $1,696.20 |
| Food and Beverage | $1,196.83 |
| Education | $766.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,198.41 | 2023-2025 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Nevro Corp. | $908.74 | 2023-2024 | Omnia, Senza |
| Saluda Medical Americas, INC. | $278.50 | 2024 | Evoke |
| Averitas Pharma INC. | $154.94 | 2025 | Qutenza |
| Spr Therapeutics, INC | $100.83 | 2024-2025 | Sprint Pns System |
| Nalu Medical, INC. | $18.53 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Muelleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.